МЕТАБОЛИЧЕСКИЕ ЭФФЕКТЫ БАРИАТРИЧЕСКИХ ОПЕРАЦИЙ

бариатрические операции, метаболический синдром, лептин, адипонектин, глюкагоноподобный пептид, глюкозонезависимый инсулинотропный пептид, грелин

1. Крапивина Н. А., Артымук Н. В., Тачкова О. А. Влияние некоторых гормонов пищевого поведения на репродуктивную функцию у женщин с ожирением // Вестн. НГ. Серия: биология и клиническая медицина. 2007. Вып. 3.

2. Кучер А. Г., Смирнов А. В., Каюков И. Г. и др. Лептин — новый гормон жировой ткани: значение в развитии ожирения, патологии сердечно-сосудистой системы и почек // Нефрология. 2005. № 1. С. 9–19.

3. Aprahamian T.A., Sam F. Adiponectin in cardiovascular inflammation and obesity // Int. J. Inflammation. 2011. Vol. 10. P. 8.

4. Arita Y., Kihara S., Ouchi N. et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity // Biochem. Biophys. Res. Commun. 1999. Vol. 257. P. 79–83.

5. Backhed F., Ding H., Wang T. et al. The gut micro- biota as an environmental factor that regulates fat storage // Proc. Natl. Acad. Sci. USA. 2004. Vol. 101. P. 15718–15723.

6. Batterham R. L., Bloom S. R. The gut hormone peptide YY regulates appetite // Ann. N.-Y. Acad. Sci. 2003. Vol. 994. P. 162–168.

7. Boey D., Sainsbury A., Herzog H. The role of peptide YY in regulating glucose homeostasis // Peptides. 2007. Vol. 28. P. 390–395.

8. Borg C. M., le Roux C. W., Ghatei M. A. et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels // Obes. Surg. 2007. Vol. 17. P. 1193–1198.

9. Buchan A. M., Pederson R. A., Koop I. et al. Morphological and functional alterations to a sub-group of regulatory peptides in human pancreas and intestine after jejuno-ileal bypass // Int. J. Obes. Relat. Metab. Disord. 1993. Vol. 17. P. 109–113.

10. Buchwald H., Avidor Y., Braunwald E. et al. Bariatric surgery: a systematic review and meta-analysis // J. A.M. A. 2004. № 292. Р. 1724–1737.

11. Buchwald H., Estok R., Fahrbach K. et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis // Am. J. Med. 2009. № 122. Р. 248–256.

12. Callahan H. S., Cummings D. E., Pepe M. S. Postprandial suppression of plasma ghrelin level is proportional to ingested caloric load but does not predict intermeal interval in humans // J. Clin. Endocrinol. Metab. 2004. Vol. 89, № 3. P. 1319–1324.

13. Cani P. D., Delzenne N. M. The role of the gut microbiota in energy metabolism and metabolic disease // Curr. Pharm. Des. 2009. Vol. 15. P. 1546–1558.

14. Chaikomin R., Doran S., Jones L. et al. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects // Am. J. Physiol. Endocrinol. Metab. 2005. Vol. 289. P. 504–507.

15. Cummings D. E., Weigle D. S., Frayo R. S. et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery // New Engl. J. Med. 2002. Vol. 346, № 21. P. 1623–1630.

16. Dixon J. B., O’Brien P. E., Playfair J. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes // J. A.M. A. 2008. Vol. 299. P. 316–323.

17. Drucker D. J. The biology of incretin hormones // Cell metabolism. 2006. Vol. 3. P. 153–165.

18. Ekblad E., Sundler F. Distribution of pancreatic polypeptide and peptide YY // Peptides. 2002. Vol. 23. P. 251–261.

19. Elrick H., Stimmler L., Hlad C. J., Arai Y. Plasma insulin response to oral and intravenous glucose administration // J. Clin. Endocrinol. Metab. 1964. Vol. 24. P. 1076–1082.

20. Frühbeck G., Caballero A. D., Gil M. J. Fundus functionality and ghrelin concentrations after bariatric surgery // New Engl. J. Med. 2004. Vol. 350, № 3. P. 308–309.

21. Geloneze B., Tambascia M. A., Pareja J. C. et al. Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes // Obesity Surgery. 2001. Vol. 11. P. 693–698.

22. Hildebrandt M. A., Hoffmann C., Sherrill-Mix S. A. et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity // Gastroenterology. 2009. Vol. 137. P. 1716–1724.

23. Holdstock C., Engström B. E., Öhrvall M. et al. Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans // J. Clin. Endocrinol. Metabolism. 2003. Vol. 88, № 7. P. 3177–3183.

24. Holst J. J. The physiology of glucagon-like peptide 1 // Physiological rev. 2007. Vol. 87. P. 1409–1439.

25. Karamanakos S. N., Vagenas K., Kalfarentzos F. et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study // Ann. Surgery. 2008. Vol. 247, № 3. P. 401–407.

26. Kim J. Y., De Wall E. Van, Laplante M. et al. Obesity associated improvements in metabolic profile through expansion of adipose tissue // J. Clin. Investigation. 2007. Vol. 117, № 9. P. 2621–2637.

27. Konstantinides S., Schafer K. et al. Leptin_dependent aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity // J. Clin. Invest. 2001. Vol. 8. P. 1533–1540.

28. Langer F.B., Hoda M. A., Bohdjalian A. et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels // Obesity Surgery. 2005. Vol. 15, №.7. P. 1024–1029.

29. Le Roux C. W., Aylwin S. J. B., Batterham R. L. et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters // Ann. Surgery. 2006. Vol. 243, № 1. P. 108–114.

30. Ley R. E., Backhed F., Turnbaugh P. et al. Obesity alters gut microbial ecology // Proc. Natl. Acad. Sci. U. S.A. 2005. Vol. 102. P. 11070–11075.

31. Ley R. E., Bäckhed F., Turnbaugh P. et al. Obesity alters gut microbial ecology // Proc. Nat. Acad. Sci. 2005. Vol. 102. P. 11070–11075.

32. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity // Nature. 2006. Vol. 444. P. 1022–1023.

33. Lin E., Gletsu N., Fugate K. et al. The effects of gastric surgery on systemic ghrelin levels in the morbidly obese // Arch. Surgery. 2004. Vol. 139, № 7. P. 780–784.

34. Maeda N., Shimomura I., Kishida K. et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 // Nat. Med. 2002. Vol. 8, № 7. P. 731–737.

35. Montague C. T., Prins J., Sanders B. et al. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution // Diabetes. 1997. Vol. 46. P. 342–347.

36. Nijhuis J., Dielen F. M.H., Buurman W. A. et al. Ghrelin, leptin and insulin levels after restrictive surgery: a 2-year follow-up study // Obesity Surgery. 2004. Vol. 14, № 6. P. 783–787.

37. Pories W. J., Macdonald K. G., Morgan E. J. et al. Surgical treatment of obesity and its effect on diabetes: 10-year follow-up // Am. J. Clin. Nutr. 1992. Vol. 55. P. 582–591.

38. Sam F., Duhaney T.A., Sato K. et al. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure // Endocrinology. 2010. Vol. 151, № 1. Р. 322–331.

39. Shibata R., Ouchi N., Kihara S. et al. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of AMP-activated protein kinase signaling // J. Biol. Chemistry. 2004. Vol. 279. № 27. P. 28670–28674.

40. Stoeckli R., Clianda R., Langer I. et al. Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass // Obesity Research. 2004. Vol. 12, № 2. P. 346–350.

41. Strader A. D., Woods S. C. Gastrointestinal hormones and food intake // Gastroenterology. 2005. Vol. 128. P. 175–191.

42. Tschop M., Smiley D. L. Ghrelin plasma levels // Diabetes. 2001. Vol. 50. Р. 707–709.

43. Toouli J., Fried M., Khan A. G. et al. Global guideline obesity. World Gastroenter. Organization. 2009. P. 26–42.

44. Turnbaugh P. J., Backhed F., Fulton L. et al. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome // Cell Host. Microbe. 2008. Vol. 3. P. 213–223.

45. Turnbaugh P. J., Hamady M., Yatsunenko T. et al. A core gut microbiome in obese and lean twins // Nature. 2009. Vol. 457. P. 480–484.

46. Turnbaugh P. J., Ridaura V. K., Faith J. J. et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnoto- biotic mice // Sci. Transl. Med. 2009. Vol. 1. P. 6–14.

47. Valverde I., Villanueva-Penacarrillo M. L., Malaisse W. J. Pancreatic and extrapancreatic effects of GLP-1 // Diabetes Metab. 2002. Vol. 28. P. 85–89.

48. Vincent R. P., le Roux C. W. Changes in gut hormones after bariatric surgery // Clin. Endocrinol. 2008. Vol. 69. P. 173–179.

49. Woelnerhanssen B., Peterli R., Steinert R. E. et al. Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy — a prospective randomized trial // Surg. Obesity and Related Diseases. 2011. Vol. 7. P. 561–568.

50. Zhanga H., DiBaiseb J. K., Zuccoloc A. et al. Human gut microbiota in obesity and after gastric bypass // PNAS. 2009. Vol. 106, № 7. P. 2365–2370.